Impax’s Zomig Nasal Spray OK’d as pediatric migraine treatment
Impax Specialty Pharma’s Zomig Nasal Spray has been approved by the Food and Drug Administration for use in children ages 12 and older for the acute treatment of migraine. Parent company Impax Laboratories Inc.